吉林中医药2024，Vol.44Issue(8)：914-918,5.DOI:10.13463/j.cnki.jlzyy.2024.08.012
刘凤斌运用药对治疗慢性萎缩性胃炎伴异型增生
Analysis of Liu Fengbin's experience in treating chronic atrophic gastritis with dysplasia by using couplet medicines
摘要
Abstract
Professor Liu Fengbin has unique insights and experience in the diagnosis and treatment of chronic atrophic gastritis with traditional Chinese medicine.He believes that its root cause lies in spleen deficiency,while qi stagnation,damp(heat)obstruction,blood stasis are its manifestations.If the disease is not controlled in time and effectively,it may lead to results of deficient spleen qi and cementation of poisonous damp-heat and static blood,and ultimately the inflammation and precancerous transformation.That is,deficiency of spleen qi and cementation of damp-heat and blood stasis constitute the key pathogeneses of chronic atrophic gastritis with dysplasia.After years of clinical practice and verification,Professor Liu Fengbin develops Fuzheng Tongluo Jiedu Formula as the core prescription for the treatment of this disease.Meanwhile,he selects different couplet medicines flexibly based on the five-zang viscera correlation theory.He advocates harmonizing the stomach for descending adverse qi,so that the blood stasis and damp-heat can be dispersed.In addition,Professor Liu Fengbin underlines dispersing stagnated liver qi,ventilating lung qi,and tranquillizing the mind to help the spleen and stomach return to their normal physiological functions.Besides,it is necessary to tonify the kidney,which helps strengthen the spleen.He is also good at using couplet medicines for promoting blood circulation and detoxication to directly target the affected areas,so that the lesions can be quickly reversed.关键词
慢性萎缩性胃炎/异型增生/药对/学术经验/刘凤斌Key words
chronic atrophic gastritis(CAG)/dysplasia/couplet medicines/academic experience/Liu Fengbin分类
医药卫生引用本文复制引用
钟晓莹,黄远程,杨泽虹,文艺,庄昆海,刘凤斌,李培武..刘凤斌运用药对治疗慢性萎缩性胃炎伴异型增生[J].吉林中医药,2024,44(8):914-918,5.基金项目
刘凤斌广东省名中医传承工作室项目(粤中医办函[2020]1号) （粤中医办函[2020]1号）
广州中医药大学"双一流"与高水平大学学科协同创新团队项目"中医药防治胃'炎-癌'转化的协同创新团队"(2021xk47) （2021xk47）
学科后备人才培育项目(A1-2601-22-415-008) （A1-2601-22-415-008）
第七批全国老中医药专家学术经验继承工作项目(国中医药人教函[2020]76号) （国中医药人教函[2020]76号）
